u/SuckWallStreetDry

Reddit r/ValueInvesting
· tracked since Feb 2026
Calls
1
Win Rate
0.0%
return
-7.8%
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 0
Win Rate 0% Long 1 Short 0
Win Rate
7d 100%
30d 0%
90d 0%
Average Return -7.8% Long Return -7.8% Short Return -
Average Return
7d +1.3%
30d -0.3%
90d -25.5%
Visual Insights Log in to see more
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
ABT 1ST Abbott L... Abbott Laboratories
Long
Feb 08
$110.83
-7.8%
Buy Abbott at ~19x forward earnings for long-term compounding
The author argues Abbott is a high-quality healthcare compounder trading at ~19x forward earnings after a Q4 2025 revenue miss. FreeStyle Libre CGM growth, cardiac devices, razor/razorblade diagnostics and emerging-market pharma should drive ~10% EPS growth and margin expansion, with multiple normalization adding upside. They see 13-16% annual returns and a 10-30% margin of safety over a 10+ year horizon. Main stated risks are NEC litigation, an IRS tax dispute, China pricing pressure, Exact Sciences integration risk, tariffs, and further downside toward the 52-week low.
MedTech
REDDIT
Showing 1 of 1 calls · sorted by mentions

u/SuckWallStreetDry has 1 trade ideas tracked on Buzzberg across 1 tickers since February 2026. Most covered: ABT.

Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology